C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/104, 167/327
C12N 5/10 (2006.01) A61K 35/12 (2006.01) A61K 38/19 (2006.01) A61K 38/37 (2006.01) A61K 38/46 (2006.01) A61K 38/49 (2006.01) A61L 27/38 (2006.01) C12N 15/867 (2006.01) A61K 38/00 (2006.01) A61K 48/00 (2006.01) C12N 5/06 (2006.01)
Patent
CA 1340427
Endothelial cells transduced with genetic material encoding a polypeptide or protein of interest and, optionally, a selectable marker, as well as methods for making and using the transduced endothelial cells. Such endothelial cells are useful in improving the performance of vascular grafts and in delivering the encoded polypeptide or protein, such as an enzyme, a hormone or a drug, to an individual who has had a graft or implant of the transduced cells.
585630
Birinyi Louis K.
Callow Allan D.
Cohen Lawrence K.
Mulligan Richard C.
Wilson James Maxwell
Birinyi Louis K.
Brigham & Women's Hospital
Callow Allan D.
Cell Genesys Inc.
Cohen Lawrence K.
LandOfFree
Genetic modification of endothelial cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic modification of endothelial cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic modification of endothelial cells will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1337097